Xometry, Inc.
NasdaqGS:XMTR Voorraadrapport
Marktkapitalisatie: US$1.5b
Xometry Toekomstige groei
Future criteriumcontroles 1/6 Xometry zal naar verwachting groeien in winst en omzet met respectievelijk 49% en 15.3% per jaar. De winst per aandeel zal naar verwachting groeien met 50.5% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 8.3% zijn.
Belangrijke informatie
50.5%
Groei van de winst per aandeel
Trade Distributors winstgroei 8.7% Inkomstengroei 15.3% Toekomstig rendement op eigen vermogen 8.3% Dekking van analisten Good
Laatst bijgewerkt 08 Nov 2024
Recente toekomstige groei-updates
Xometry, Inc. Provides Earnings Guidance for the Fourth Quarter 2024 Nov 05
Forecast to breakeven in 2026 Aug 08
Xometry, Inc. Provides Earnings Guidance for Third Quarter 2024 Aug 08
Price target decreased by 9.4% to US$22.25 Jun 06
Consensus EPS estimates fall by 38% May 16
Xometry, Inc. Provides Earnings Guidance for Send Quarter 2024 May 10
Toon alle updates
New major risk - Share price stability Nov 07
Third quarter 2024 earnings: EPS and revenues exceed analyst expectations Nov 06
Xometry, Inc. Provides Earnings Guidance for the Fourth Quarter 2024 Nov 05
Xometry: Marketplace Sales More Than Doubled While Peers' Organic Revenue Declined Nov 04
Xometry Appoints Roy Azevedo to its Board of Directors Oct 17
Xometry, Inc. to Report Q3, 2024 Results on Nov 05, 2024 Oct 15
Would Xometry (NASDAQ:XMTR) Be Better Off With Less Debt? Oct 02
Revenues Tell The Story For Xometry, Inc. (NASDAQ:XMTR) As Its Stock Soars 29% Aug 18
Xometry Unveils Instant Pricing, Lead Time Offerings for Tube Cutting, Tube Bending Aug 13
Xometry: Rebounding On Resilient Growth Aug 13
Second quarter 2024 earnings: EPS and revenues exceed analyst expectations Aug 09
New minor risk - Share price stability Aug 09
Forecast to breakeven in 2026 Aug 08
Xometry, Inc. Provides Earnings Guidance for Third Quarter 2024 Aug 08
Xometry, Inc. to Report Q2, 2024 Results on Aug 08, 2024 Jul 16
Xometry, Inc.(NasdaqGS:XMTR) dropped from Russell Small Cap Comp Value Index Jul 03
Not Many Are Piling Into Xometry, Inc. (NASDAQ:XMTR) Stock Yet As It Plummets 26% Jul 02
Insufficient new directors Jul 01
We Think Xometry (NASDAQ:XMTR) Has A Fair Chunk Of Debt Jun 12
Price target decreased by 9.4% to US$22.25 Jun 06
Chief Sales Officer recently bought US$308k worth of stock Jun 02
Consensus EPS estimates fall by 38% May 16
Xometry, Inc. Announces Executive Changes May 16
Xometry: Persistent Demand Headwinds May 13
Xometry, Inc. Provides Earnings Guidance for Send Quarter 2024 May 10
First quarter 2024 earnings released: US$0.34 loss per share (vs US$0.39 loss in 1Q 2023) May 09
Xometry, Inc., Annual General Meeting, Jun 18, 2024 May 01
Xometry, Inc. to Report Q1, 2024 Results on May 09, 2024 Apr 24
Insufficient new directors Apr 01
Xometry Inc. Introduces Enhanced Teamspace Collaboration Features to Further Expedite Order Management on Its Ai-Powered Marketplace Mar 28
What You Can Learn From Xometry, Inc.'s (NASDAQ:XMTR) P/SAfter Its 44% Share Price Crash Mar 28
Xometry: Downgrading To Hold As The Market Focus Has Shifted To The Near-Term Outlook Mar 22
Consensus EPS estimates fall by 96% Mar 07
Xometry: Overreaction To Conservative Guidance Mar 05
Full year 2023 earnings: EPS misses analyst expectations Mar 01
No longer forecast to breakeven Mar 01
Xometry, Inc. Appoints James Miln as Principal Financial Officer and Principal Accounting Officer, Effective as of March 1, 2024 Mar 01
New minor risk - Share price stability Mar 01 Xometry, Inc. Announces Chief Financial Officer Changes, Effective as of March 1, 2024
Xometry: A Well-Priced Opportunity In The Market Feb 20
Is Xometry (NASDAQ:XMTR) Using Too Much Debt? Feb 19
Xometry, Inc. to Report Q4, 2023 Results on Feb 29, 2024 Feb 14
Are Investors Undervaluing Xometry, Inc. (NASDAQ:XMTR) By 39%? Jan 23
Price target increased by 13% to US$34.00 Jan 19
Price target increased by 7.3% to US$25.75 Dec 22
Independent Chairman of the Board notifies of intention to sell stock Dec 10
Xometry Updates Process Recommender to Its Ai-Powered Instant Quoting Engine Dec 06
Market Participants Recognise Xometry, Inc.'s (NASDAQ:XMTR) Revenues Pushing Shares 54% Higher Dec 05
Xometry, Inc. Announces Changes to its Board Dec 05
Chief Operating Officer recently sold US$349k worth of stock Dec 04
Xometry, Inc. Announces Resignation of Bill Cronin as Chief Revenue Officer, Effective Date January 5, 2024 Nov 30
Chief Technology Officer recently sold US$423k worth of stock Nov 24
Chief Technology Officer notifies of intention to sell stock Nov 18
New minor risk - Profitability Nov 17
Forecast to breakeven in 2025 Nov 13
Third quarter 2023 earnings: EPS exceeds analyst expectations Nov 10
Xometry, Inc. Provides Revenue Guidance for the Fourth Quarter of 2023 Nov 10
Xometry, Inc. to Report Q3, 2023 Results on Nov 09, 2023 Oct 24
Xometry’s Thomas Expands Self-Serve Listing Categories on its Thomasnet.com Platform Sep 14
Independent Chairman of the Board notifies of intention to sell stock Sep 03
Independent Chairman of the Board recently sold US$414k worth of stock Aug 18
Xometry, Inc. Adds New Dashboard Collaboration Tool to Its AI-Powered Marketplace Aug 17
Consensus EPS estimates fall by 17% Aug 16
Independent Chairman of the Board notifies of intention to sell stock Aug 14
No longer forecast to breakeven Aug 10
Xometry, Inc. Provides Revenue Guidance for the Third Quarter and Full Year of 2023 Aug 10
Xometry, Inc. (NASDAQ:XMTR) Shares Could Be 26% Below Their Intrinsic Value Estimate Jul 14 Xometry, Inc. to Report Q2, 2023 Results on Aug 09, 2023 Jul 13
Xometry, Inc. Further Expands Offerings on Its AI-Powered Marketplace Jul 11
New major risk - Share price stability Jul 06
Now 20% undervalued Jun 23
Chief Operating Officer recently sold US$172k worth of stock Jun 18
Chief Operating Officer notifies of intention to sell stock Jun 17
Xometry, Inc. Provides Revenue Guidance for the Second Quarter and Full Year of 2023 May 11
First quarter 2023 earnings: EPS and revenues exceed analyst expectations May 11
Full year 2022 earnings: EPS and revenues miss analyst expectations Mar 17
An Intrinsic Calculation For Xometry, Inc. (NASDAQ:XMTR) Suggests It's 28% Undervalued Mar 13
Consensus EPS estimates fall by 41% Mar 03
Price target decreased by 28% to US$38.20 Mar 02
Forecast to breakeven in 2025 Mar 02
Xometry, Inc. to Report Q4, 2022 Results on Mar 01, 2023 Feb 16
Chief Financial Officer exercised options and sold US$306k worth of stock Feb 03
Co-Founder recently sold US$64k worth of stock Jan 08
Chief Financial Officer exercised options and sold US$281k worth of stock Jan 05
Co-Founder recently sold US$177k worth of stock Dec 05
Independent Director exercised options and sold US$60k worth of stock Nov 30
Chief Operating Officer exercised options to buy US$679k worth of stock. Nov 24
Third quarter 2022 earnings: EPS exceeds analyst expectations Nov 16
Price target decreased to US$57.29 Nov 12 Xometry, Inc. Reports Impairment of Long-Lived Assets for Three Months Ended September 30, 2022
Co-Founder recently sold US$98k worth of stock Nov 04
Independent Director exercised options and sold US$94k worth of stock Oct 27
Winst- en omzetgroeiprognoses NasdaqGS:XMTR - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions ) Datum Inkomsten Inkomsten Vrije kasstroom Geldmiddelen uit operationele activiteiten Gem. Aantal analisten 12/31/2026 754 -14 8 22 8 12/31/2025 647 -29 -12 4 10 12/31/2024 543 -50 -45 -27 10 9/30/2024 525 -51 -46 -26 N/A 6/30/2024 502 -53 -47 -28 N/A 3/31/2024 481 -66 -44 -25 N/A 12/31/2023 463 -67 -48 -30 N/A 9/30/2023 433 -84 -62 -46 N/A 6/30/2023 418 -87 -68 -51 N/A 3/31/2023 403 -77 -70 -55 N/A 12/31/2022 381 -79 -76 -63 N/A 9/30/2022 350 -76 -88 -77 N/A 6/30/2022 303 -75 -91 -82 N/A 3/31/2022 258 -71 -90 -83 N/A 12/31/2021 218 -61 -75 -69 N/A 9/30/2021 189 -48 -48 -42 N/A 6/30/2021 174 -48 -36 -31 N/A 3/31/2021 159 -42 -30 -26 N/A 12/31/2020 141 -40 -26 -22 N/A 12/31/2019 80 -31 -30 -27 N/A
Meer tonen
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachting is dat XMTR de komende 3 jaar verliesgevend zal blijven.
Winst versus markt: De verwachting is dat XMTR de komende 3 jaar verliesgevend zal blijven.
Hoge groeiwinsten: De verwachting is dat XMTR de komende 3 jaar verliesgevend zal blijven.
Omzet versus markt: De omzet van XMTR ( 15.3% per jaar) zal naar verwachting sneller groeien dan de markt US ( 8.9% per jaar).
Hoge groei-inkomsten: De omzet van XMTR ( 15.3% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen XMTR zal naar verwachting over 3 jaar laag zijn ( 8.3 %).
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
